Consecutive series of liver resections. Analysis of morbimortality in a newly created center

Abstract

levels of AFP that had loco-regional treatment followed by liver transplant with no tumor recurrence 24 months posttransplant. Methods:Results: This is a case of a 55-year-old male who had endstage liver disease due to Hepatitis C Virus (HCV) infection since 2008, and was treated with ribavirin and interferon. He was diagnosed with HCC lesion 2.6 cm in the maximal diameter in April 2014. AFP was 341 IU/mL that jumped to 2599 IU/mL. He underwent transarterial chemoembolization that showed a dramatic drop of AFP down to 21 IU/mL after six weeks.The patient was listed for liver transplant as HCC was within Milan criteria. He underwent liver transplant in September 2014 when AFP was 9 IU/mL. He had an uneventful liver transplant with uncomplicated post-operative course and was discharged in a good condition on the twelfth post-operative day.Serial follow-up of the patient with dynamic magnetic resonance imaging and serum AFP for 24 months posttransplant showed no recurrence of HCC with normal levels of AFP. Conclusion: Exclusion of patients based on their initial serum Alfa-fetoprotein levels at time of diagnosis of HCC could preclude patients with potentially favorable outcome.